TALS News and Press, Talaris Therapeutics Inc.

2023-10-19 11:16:03 ET Talaris Therapeutics ( NASDAQ: TALS ) had declared $1.5118/share special dividend . Payable Oct. 20; for shareholders of record Oct. 16; ex-div Oct. 20. See TALS Dividend Scorecard, Yield Chart, & Dividend Growth. For further detail...

2023-10-17 18:51:58 ET More on Talaris Therapeutics Talaris sells kidney transplant asset FCR001 to ImmunoFree Seeking Alpha’s Quant Rating on Talaris Therapeutics Historical earnings data for Talaris Therapeutics Financial information for Talaris Ther...

Combined Company to Trade on Nasdaq Under Ticker “TRML” Talaris Announces 1-for-10 Reverse Stock Split of Common Stock BOSTON, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. (Nasdaq: TALS) (“Talaris”) today announced the results of the special...

Special dividend estimated to be $1.5118 per share Payment of special dividend conditioned upon closing of merger, which is subject to stockholder approval BOSTON, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. (Nasdaq: TALS) (“Talaris” or the “C...

NEW YORK and BOSTON, Oct. 04, 2023 (GLOBE NEWSWIRE) -- New York Blood Center Enterprises (NYBCe) and Talaris Therapeutics, Inc. (Nasdaq: TALS) (“Talaris”) announced today NYBCe’s acquisition of commercial-scale cell and gene therapy development and manufacturing facilities, a...

NEW YORK, NY / ACCESSWIRE / October 2, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Renovaro Biosciences Inc. (NASDAQ:R...

NEW YORK, NY / ACCESSWIRE / July 30, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: American National Bankshares Inc. (NA...

2023-07-18 03:22:33 ET Summary Failed biopharma Talaris Therapeutics has finally reached a strategic review conclusion, delivering a 37% return to us over the last two months. The company has agreed to merge with a late-stage biopharma Tourmaline Bio. There might still be furt...

NEW YORK, NY / ACCESSWIRE / June 29, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Talaris Therapeutics, Inc. (NASDAQ:TA...

2023-06-26 15:40:03 ET Navigating the world of penny stocks can often feel like a dance, full of rhythm, calculated movements, and unexpected twists. One of the popular styles in this domain is swing trading, a strategy where investors profit from the ‘swing’ or fluctuatio...